Article
Extended Data Fig. 2 | Summary of mAb screening of transfection
supernatants. a, Numbers of binding and neutralizing antibodies from
patients 1 to 5. b, The best-fit pseudovirus neutralization curves for 130
samples that were positive in at least one of the screens shown in Fig. 1b.
The 18 transfection supernatants that showed evidently better potency are
highlighted in colours, while others with non-neutralizing or weakly
neutralizing activities are shown in grey. One additional supernatant (Patient 1)
that was initially missed in the pseudovirus screen but later found to be a
potent neutralizing mAb (1-87) is also highlighted.